UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
|
(State or other jurisdiction of |
|
(Commission |
|
(I.R.S. Employer |
|
Incorporation or Organization) |
|
File Number) |
|
Identification No.) |
(Address of principal executive office) (Zip Code)
Registrant’s telephone number, including area code (
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
|
Item 1.02 |
Termination of a Material Definitive Agreement. |
On September 28, 2020 (the “Redemption Date”), Universal Health Services, Inc. (the “Company”) redeemed the entire $700 million aggregate principal amount of its 4.75% Senior Secured Notes due 2022 (the “2022 Notes”) issued and outstanding, at a cash redemption price equal to the sum of (A) 100% of the aggregate principal amount of the 2022 Notes redeemed, and (B) accrued and unpaid interest on the 2022 Notes to the Redemption Date. The 2022 Notes were issued under the Indenture (the “Indenture”), dated as of August 7, 2014, among the Company, the subsidiary guarantors party thereto, MUFG Union Bank, N.A., as trustee (the “Trustee”), and JPMorgan Chase Bank, N.A., as collateral agent (the “Collateral Agent”), as supplemented by the First Supplemental Indenture, dated as of June 3, 2016, among the Company, the subsidiary guarantors party thereto, the Trustee and the Collateral Agent. The Company’s 3.75% Senior Secured Notes due 2019, which had also been issued under the Indenture, were redeemed in full on November 26, 2018. Accordingly, the Indenture has been satisfied and discharged.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Universal Health Services, Inc. |
||
|
|
||
|
By: |
|
/s/ Steve Filton |
|
Name: Steve Filton |
||
|
Title: Executive Vice President and Chief Financial Officer |
||
Date: September 30, 2020